Key result
Loss of Rgs5 in mice provoked exaggerated bradycardia and prolonged sinus nodal recovery time, whereas Rgs5 overexpression conferred resistance to acetylcholine-related bradycardia and AT.
Why the study?
Does Rgs5 regulate vagal-related bradycardia and atrial tachyarrhythmia through IKA ch current in mice?
Does Rgs5 regulate vagal-related bradycardia and atrial tachyarrhythmia through IKA ch current in mice?
Rgs5 acts as a critical regulator of parasympathetic activation in the heart, preventing vagal-related bradycardia and atrial tachyarrhythmia by negatively regulating the IKA ch current.
Answers are grounded in this paper and cite their sources.
Rgs5 modulation may affect vagal responses in mice; hypothesis-generating for human arrhythmias, requires clinical validation.
BACKGROUND: The regulator of G-protein signaling 5 (Rgs5), which functions as the regulator of G-protein-coupled receptor (GPCR) including muscarinic receptors, has a potential effect on atrial muscarinic receptor-activated IKA ch current. METHODS AND RESULTS: In the present study, hearts of Rgs5 knockout (KO) mice had decreased low-frequency/high-frequency ratio in spectral measures of heart rate variability. Loss of Rgs5 provoked dramatically exaggerated bradycardia and significantly (P<0.05) prolonged sinus nodal recovery time in response to carbachol (0.1 mg/kg, intraperitoneally). Compared to those from wild-type (WT) mice, Langendorff perfused hearts from Rgs5 KO mice had significantly (P<0.01) abbreviated atrial effective refractory periods and increased dominant frequency after administration of acetylcholine (ACh; 1 μmol/L). In addition, whole patch clamp analyses of single atrial myocytes revealed that the ACh-regulated potassium current (IKA ch) was significant increased in the time course of activation and deactivation (P<0.01) in Rgs5 KO, compared to those in WT, mice. To further determine the effect of Rgs5, transgenic mice with cardiac-specific overexpression of human Rgs5 were found to be resistant to ACh-related effects in bradycardia, atrial electrophysiology, and atrial tachyarrhythmia (AT). CONCLUSION: The results of this study indicate that, as a critical regulator of parasympathetic activation in the heart, Rgs5 prevents vagal-related bradycardia and AT through negatively regulating the IKA ch current.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2016) studied Vagal-related bradycardia and atrial tachyarrhythmia. Rgs5 knockout and Rgs5 overexpression vs. Wild-type mice was evaluated on Sinus nodal recovery time, atrial effective refractory periods, and IKA ch current (p=<0.05). Loss of Rgs5 in mice provoked exaggerated bradycardia and prolonged sinus nodal recovery time, whereas Rgs5 overexpression conferred resistance to acetylcholine-related bradycardia and AT.
Synapse has enriched 10 related papers. Consider them for comparative context: